Collaboration - May 10, 2019
First company to test digital products at Testa Center
The Finnish company SciAR has a primary position twice: as a first company to test digital product in the facility, as well as a first actor outside Sweden to use Testa Center. SciAR creates software for Augmented Reality (AR) and Mixed Reality (MR) to take human errors out of the equation in life science laboratories. […]
Collaboration - May 9, 2019
Pilloxa to collaborate with Sandoz
The Swedish digital startup company Pilloxa has announced that it is to collaborate with Sandoz Nordics on using Pillox’s smart pillbox in the field of transplantation. The initial phase aims to support Swedish transplant clinics with Pilloxa’s innovation in order to facilitate improved medication adherence by transplanted patients. A patient centric adherence platform Pilloxa originates from the […]
Collaboration - May 8, 2019
KI Innovations & AstraZeneca to support Nordic life science start-up companies
KI Innovations has announced a new collaboration with AstraZeneca Exchange Mentoring to help start-up companies access big pharma insights. AstraZeneca Exchange Mentoring initiative provides business-to-business mentoring to help start-up companies and entrepreneurs convert their ideas into long-term success. “This is a great opportunity for the start-ups at KI Innovations and we are pleased to enter this […]
Collaboration - May 3, 2019
Kuopio – All elements are in place for a strong life science profile
Kuopio combines a great business environment, strong international networks and a wide range of education and research expertise. Kuopio lies in the beautiful Finnish Lakeland, where there is more water than land, and from its very beginning in 1775 it has been a center of education. “A “trivium” school offering secondary education was founded in […]
Collaboration - April 30, 2019
AstraZeneca starts artificial intelligence collaboration
AstraZeneca and BenevolentAI has began a long-term collaboration to use artificial intelligence (AI) and machine learning for the discovery and development of new treatments for chronic kidney disease (CKD) and idiopathic pulmonary fibrosis (IPF). Scientists from the two organisations will work side-by-side to combine AstraZeneca’s genomics, chemistry and clinical data with BenevolentAI’s target identification platform […]
Collaboration - April 23, 2019
Novo Nordisk and Gilead Sciences initiate collaboration
The two companies intend to collaborate on a clinical trial combining compounds from their respective pipelines in nonalcoholic steatohepatitis (NASH). The intended clinical trial will be a proof-of-concept study combining Novo Nordisk’s semaglutide (GLP-1 analogue) and Gilead’s cilofexor (FXR agonist) and firsocostat (ACC inhibitor) for the treatment of patients with NASH. The companies are also […]
